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The interruption of tissue oxygenation – ischemia – is
probably the most important problem associated with liver
surgery [1,2]. This is especially true for patients with
impaired liver function, such as liver cirrhosis or steatosis,
where the effects of ischemic injury may be irreversible even
if the duration of the interruption of blood flow is short.
Paradoxically, the generation of reactive oxygen species
(ROS) seems to be a key factor in the development of liver
damage in irreversible ischemia. The answer to this apparent
paradox lies in that ROS are generated not during the initial
period of ischemia but upon restoration of blood flow or
reperfusion. During ischemia, a variety of cellular and mole-
cular events take place in the liver that, upon reoxygenation,
result in the massive production of ROS, which inflict direct
tissue damage and initiate a cascade of deleterious cellular
responses leading to inflammation, cell death, and organ fail-
ure. The term ischemia-reperfusion (IR) injury has been
coined to indicate this condition. Therapeutic strategies
aimed to prevent IR injury are focused on controlling ROS
generation at the time of restoration of blood flow or reperfu-
sion, and intervening in the signal cascade initiated by reox-
ygenation.
Liver injury induced by hepatic IR is characterized by
activation of the transcription factor NF-kB, activation of
Kupffer cells, increased production of proinflammatory
cytokines, such as tumour necrosis factor-a (TNF-a) and
interleukin-1 (IL-1), liver polymorphonuclear (PMN)
leukocyte activation and infiltration, and hepatocellular
damage [2]. TNF-a is an important mediator in PMN leuko-
cyte recruitment and activation which in turn are a potent
source of ROS. In view of this critical role played by TNF-a
in liver injury, it has been long proposed that suppression of
TNF-a production may attenuate liver injury after IR. Thus,
anti-TNF-a antibodies [3] and suppression of cytokine
generation with FR167653 [4] decrease hepatic IR injury
in experimental models.
Recent studies indicate that Kupffer cells play a key role
in the generation of TNF-a during IR liver injury [5]. For
instance, the inhibition of TNF-a release from Kupffer cells
with gadolinium chloride (GdCl3), previous to the IR treat-
ment, maintained low levels of TNF-a attenuating liver
injury, an effect that could be reverted by the administration
of exogenous TNF-a [6,7]. In addition to GdCl3, and other
inhibitors of Kupffer cell activation, a variety of different
pharmacological approaches, such as the administration of
adenosine [8], nitric oxide donors [9], and antioxidants
[10,11], have been successfully applied in animal models
to attenuate liver injury after IR. Identifying the mechan-
isms of action by which these and other agents provide
ischemic tolerance will provide potential targets for the
development of new treatments for IR liver injury.
It is known for many years that cellular injury, indepen-
dently of its nature (infectious, oxygen deprivation, inflam-
matory, heat, etc.), induces an adaptive response.
Accordingly, another therapeutic strategy aimed to amelio-
rate hepatic IR injury consists in the exposure of the liver to
brief periods of blood flow interruption followed by reper-
fusion prior to the prolonged IR treatment, a procedure that
is know as ischemic preconditioning. The protective effects
of ischemic preconditioning were first described in the
myocardium and have been also shown experimentally in
the liver. It has been recently demonstrated that ischemic
preconditioning protects sinusoidal endothelial cells and
suppresses Kupffer cell activation after storage and reperfu-
sion [12].
Heat shock proteins (HSPs) are well known as cytopro-
tective proteins. Accordingly, different groups have inves-
tigated whether a period of hyperthermia followed by
recovery from this heat treatment is another mechanism
for acquiring ischemic tolerance. Heat shock pretreatment
has been shown to prevent hepatic ischemic injury caused
by Pringle’s manoeuvre [13] and in an isolated rat liver
perfusion model [14]. Heat shock preconditioning has
been also shown to reduce liver injury induced by carbon
tetrachloride administration [15] and to improve liver trans-
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plant survival in rats [16]. Moreover, geranylgeranylacetone
(GGA), a heat shock protein inducer, has been recently
shown to prevent primary graft malfunction in a model of
rat liver transplantation [17]. Since GGA is a non-toxic anti-
ulcer drug, it has been proposed that oral administration of
this agent may be useful in preventing IR liver injury [17].
In this model of liver transplantation, GGA pretreatment
increased the hepatic mRNA levels of HSP72 and HSP 90
and reduced the serum levels of TNF-a after reperfusion
(17), suggesting that heat shock preconditioning induces
ischemic tolerance acting directly through the liver. In this
issue of the Journal, Yonezawa and colleagues [18] demon-
strate that hyperthermic preconditioning attenuates IR liver
injury acting at the organ level through the suppression of
Kupffer cell activation and neutrophil infiltration, while
providing a protective effect on the parenchymal cells.
The authors first found that heat shock preconditioning
markedly induced HSP72 expression in the different types
of cells that exist in the liver -hepatocytes, Kupffer cells and
endothelial cells. Then, they observed that the increase in
plasma TNF-a and in hepatic TNF-a mRNA during reper-
fusion was significantly suppressed by heat shock precondi-
tioning. In these experiments, Yonezawa and colleagues
immersed a group of rats in a hot water bath for 15 min to
maintain their rectal temperature at 428C. The control group
of rats was immersed in a bath maintained at 378C for the
same period of time. After 48 h recovery, partial hepatic
ischemia was induced by clamping the vessels of the left
hepatic lobes; and after a 90 min ischemia, the vessels were
unclamped. Plasma was collected and the left lobes of the
livers were removed before clamping, at reperfusion and at
various times after reperfusion. They also found that the
increase in plasma alanine amino transferase (ALT) levels
during the reoxygenation period was less marked in the heat
shock pretreated animals than in the control rats. Histologi-
cal examination of the livers confirmed that heat shock
pretreatment preserved the tissue integrity during reperfu-
sion. The production of cytokine-induced neutrophil
chemoattractant, a potent chemoattractant for neutrophils
in rats, was also suppressed in the heat shock pretreated
animals. Consistently, while reperfusion induced an intense
infiltration of PMNs in the hepatic parenchyma of the
control group, particularly in necrotic areas, in the heat
shock pretreated group the number of PMNs was smaller
and were only found in the hepatic triad.
In summary, the studies of Yonezawa and colleagues
demonstrate that the stress produced by hyperthermic
preconditioning induces tolerance to a future ischemic insult
acting directly on the various cell types of the liver – hepa-
tocytes, Kupffer cells and endothelial cells. But how does
heat shock preconditioning works its protective effect on
liver cells? One possibility is that HSP72, the major heat
shock protein, may prevent Kupffer cells from activation in
response to IR injury by suppressing NF-kB activation. NF-
kB is normally kept in an inactive state outside the nucleus
by its binding partner, I-kB. Phosphorylation of this inhibi-
tor by the I-kB kinases leads to its degradation and the
release of NF-kB, which can then migrate to the nucleus
and activate target genes. Although Yonezawa and collea-
gues did not determine NF-kB activation or I-kB phosphor-
ylation in their experimental model, different studies
indicate that hyperthermia suppresses I-kB phosphorylation
and NF-kB activation in a variety of cellular systems includ-
ing astroglial cells, RAW 264.7 murine macrophages, rat
and human islets, murine lung epithelium and rat hepato-
cytes [19–23]. Recently, Frossard and colleagues have
demonstrated that hyperthermia in rats decreases the sever-
ity of cerulein-induced pancreatitis by reducing TNFa
expression in the pancreas through the stabilization I-kB
and the suppression of NF-kB activation [24]. Suppression
by heat shock preconditioning of NF-kB activation in
response to IR may be then the mechanism by which the
production of TNF-a from Kupffer cells is inhibited. The
reduced production of TNF-a by Kupffer cells in response
to IR after heat shock preconditioning will reduce, in its
turn, the cytotoxic effect of this cytokine on the hepatocytes
(which depends also on the activation of NF-kB), limit the
infiltration of PMNs to the liver and ameliorate tissue
damage.
Based on these studies about how heat shock precondi-
tioning protects the liver from IR injury, Yonezawa and
colleagues propose that, although hyperthermia is still an
experimental treatment, patients undergoing liver surgery
may benefit from the future improvement of extracorporeal
local hyperthermic technologies using, for instance, radio
frequency irradiation. However, as reviewed recently by
DeMeester and colleagues [25], it should be remembered
that when cells or animals have been previously ‘primed’ by
exposure to endotoxins a subsequent heat stress may preci-
pitate cell death by apoptosis – a phenomenon which has
been named ‘the heat shock paradox’ [25]. Therefore, a
clear understanding of the signaling pathways activated by
heat shock and inflammation and how these stress responses
interact seems necessary before evaluation of the therapeu-
tic potential of hyperthermia.
References
[1] Hui AM, Kawasaki S, Makuuchi M, Nakayama J, Ikegami T, Miya-
gawa S. Liver injury following normothermic ischemia in steatotic rat
liver. Hepatology 1994;20:1287–1293.
[2] Serracino-Inglott F, Habib NA, Mathie RT. Hepatic ischemia-reper-
fusion injury. Am J Surg 2001;181:160–166.
[3] Colletti LM, Remick DG, Burtch GD, Kunkel SL, Strieter RM,
Campbell Jr DA. Role of tumour necrosis factor-alpha in the patho-
physiologyc alterations after hepatic ischemia/reperfusion injury in
the rat. J Clin Invest 1990;85:1936–1943.
[4] Hato S, Urakami A, Yamano T, Uemura T, Ota T, Hirai R, Shimizu N.
Attenuation of liver and lung injury after hepatic ischemia and reper-
fusion by a cytokine-suppressive agent, fr167653. Eur Surg Res
2001;33:202–209.
[5] Wanner GA, Ertel W, Muller P, Hofer Y, Leiderer R, Menger MD,
Messmer K. Liver ischemia and reperfusion induces a systemic
J.M. Mato et al. / Journal of Hepatology 35 (2001) 663–665664
inflammatory response through Kupffer cell activation. Shock
1996;5:34–40.
[6] Peralta C, Prats N, Xaus C, Gelpi E, Rosello-Catafau J. Protective
effect of liver ischemic preconditioning on liver and lung injury
induced by hepatic ischemia-reperfusion in the rat. Hepatology
1999;30:1481–1489.
[7] Mosher B, Dean R, Harkema J, Remick D, Palma J, Crockett E.
Inhibition of Kupffer cells reduced cxc chemokine production and
liver injury. J Surg Res 2001;99:201–210.
[8] Todo S, Zhu Y, Zhang S, Jin MB, Ishizaki N, Tanaka H, Subbotin V,
Starzl TE. Attenuation of ischemic liver injury by augmentation of
endogenous adenosine. Transplantation 1997;63:217–223.
[9] Liu P, Xu B, Spokas E, Lai PS, Wong PY. Role of endogenous nitric
oxide in TNF-alpha and IL-1beta generation in hepatic ischemia-
reperfusion. Shock 2000;13:217–223.
[10] Koeppel TA, Lehmann TG, Thies JC, Gehrcke R, Gebhard MM,
Herfarth C, et al. Impact of N-acetylcysteine on the hepatic micro-
circulation after orthopic liver transplantation. Transplantation
1996;61:1397–1402.
[11] Dunne JB, Alexander B, Williams R, Tredger JM. Evidence that S-
adenosyl-l-methionine diastereoisomers may reduce ischaemia-
reperfusion injury by interacting with purinoceptors in isolated rat
liver. Br J Pharmacol. 1998;125:225–233.
[12] Arai M, Thurman RG, Lemasters JJ. Ischemic preconditioning of rat
livers against cold storage-reperfusion injury: role of nonparenchymal
cells and the phenomenon of heterologous preconditioning. Liver
Transpl 2001;7:292–299.
[13] Saad S, Kanai M, Awane M, Yamamoto Y, Morimoto T, Isselhard W,
et al. Protective effect of heat shock pretreatment with heat shock
protein induction before hepatic warm ischemic injury caused by
Pringle’s manoeuvre. Surgery 1995;118:510–516.
[14] Terajima H, Enders G, Thiaener A, Hammer C, Kondo T, Thiery J, et
al. Impact of hyperthermic preconditioning on postischemic hepatic
microcirculatory disturbances in an isolated perfusion model of the rat
liver. Hepatology 2000;31:407–415.
[15] Yamamoto H, Yamamoto Y, Yamagami K, Kume M, Kimoto S,
Toyokuni S, et al. Heat-shock preconditioning reduces oxidative
protein denaturation and ameliorates liver injury by carbon tetrachlor-
ide in rats. Res Exp Med 2000;199:309–318.
[16] Matsumoto K, Honda K, Kobayashi N. Protective effect of heat
preconditioning of rat liver graft resulting in improved transplant
survival. Transplantation 2001;71:862–868.
[17] Fudaba Y, Ohdan H, Tashiro H, Ito H, Fukuda Y, Dohi K, Asahara T.
Geranylgeranylacetone, a heat shock protein inducer, prevents
primary graft non-function in rat liver transplantation. Transplanta-
tion 2001;71:184–189.
[18] Yonezawa K, Yamamoto Y, Yamamoto H, Ishikawa Y, Uchinami H,
Taura K, et al. Suppression of tumor necrosis factor-a production and
neutrophil infiltration during ischemia-reperfusion injury of the liver
after heat shock preconditioning. J Hepatol 2001;35:619–627.
[19] Feinstein DL, Galea E, Aquino DA, Li GC, Xu H, Reis DJ. Heat
shock protein 70 suppresses astroglial-inducible nitric oxide synthase
expression by decreasing NFkappaB activation. J Biol Chem
1996;271:17724–17732.
[20] Shanley TP, Ryan MA, Eaves-Pyles T, Wong HR. Heat shock inhibits
phosphorylation of I-kappaBalpha. Shock 2000;14:447–450.
[21] Scarim AL, Heitmeier MR, Corbett JA. Heat shock inhibits cytokine-
induced nitric oxide synthase expression by rat and human islets.
Endocrinology 1998;139:5050–5057.
[22] Wong HR, Ryan M, Wispe JR. The heat shock response inhibits
inducible nitric oxide synthase gene expression by blocking I
kappa-B degradation and NF-kappa B nuclear translocation. Biochem
Biophys Res Commun 1997;231(2):257–263.
[23] de Vera ME, Kim YM, Wong HR, Wang Q, Billiar TR, Geller DA.
Heat shock response inhibits cytokine-inducible nitric oxide synthase
expression in rat hepatocytes. Hepatology 1996;24:1238–1245.
[24] Frossard JL, Pastor CM, Hadengue A. Effect of hyperthermia on NF-
kappaB binding activity in cerulein-induced acute pancreatitis. Am J
Physiol Gastrointest Liver Physiol 2001;280:G1157–G1162.
[25] DeMeester SL, Buchman TG, Cobb P. The heat shock paradox: does
NF-kB determine cell fate? FASEB J 2001;15:270–274.
J.M. Mato et al. / Journal of Hepatology 35 (2001) 663–665 665
